Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


This study aimed to determine whether a programme to support women monitoring their own blood pressure through pregnancy was practical to implement, and acceptable. The study results helped us to develop schedules for self-monitoring and thresholds for the diagnosis of raised blood pressure in pregnancy based on the home readings.  The BUMP trials are now underway

Why this is important:

Self-monitoring of blood pressure in pregnant women has potential to be a successful approach in the detection of gestational hypertensive disorders (raised blood pressure) that include pre-eclampsia. (Hodgkinson et al., 2014)

Self-monitoring could be a more reliable way of detecting raised blood pressure in pregnancy, it could detect serious problems sooner or would avoid unnecessary medication. - Dr Katherine Tucker, University of Oxford.

Pre-eclampsia affects around 5% of pregnancies in the UK and is defined as high blood pressure combined with protein leaking into the urine. Pre-eclampsia can lead to eclampsia; a serious condition with seizures and a high mortality rate. Around one in six women who die in pregnancy have pre-eclampsia or eclampsia.

The diagnosis of pre-eclampsia requires monitoring of blood pressure and urine, typically by midwives at intermittent antenatal visits. Women considered to be at higher risk for pre-eclampsia, for instance due to age or a previous history, require more frequent monitoring. However a number of women in the UK develop pre-eclampsia within the interval between antenatal visits.

Regular monitoring of blood pressure and proteinuria would be reasonably expected to improve detection of pre-eclampsia in the high risk pregnant population. One solution is for women to monitor their own health through pregnancy, this would reduce the time, expense and inconvenience of frequent appointments without compromising the ability to detect and monitor a potentially serious disease.


We recently carried out a prospective observational study of self-monitoring of blood pressure in Oxfordshire and Birmingham. Patients were invited to participate if they are defined by the NICE guidelines as at higher risk of pre-eclampsia (NICE clinical guideline 62). This included women with any of the following risk factors:

Age 40 years or older
First pregnancy
Pregnancy interval of more than 10 years
Family history of pre-eclampsia
Previous history of pre-eclampsia
Body mass index (BMI) 30 kg/m2 or above at booking
Pre-existing vascular disease such as hypertension
Pre-existing renal disease
Multiple pregnancy

201 participants were recruited from April 2013 to January 2014 and asked to measure their blood pressure morning and evening, three times a week.

Participants experiencing any symptoms of pre-eclampsia or recording a raised home reading (>140 SBP and / or 90 DBP mmHg), that did not settle when measured in triplicate, were advised to contact their midwife, GP or maternity assessment unit for clinic blood pressure and proteinuria testing as appropriate. Women were able to text their BP results which could be seen by the research team.

Read more about Florence: The NHS self-care service

The acceptability and feasibility of this intervention has been assessed by participant questionnaires and interviews in a linked qualitative study that will be published as part of a module on pre-eclampsia on the in 2016  

How this could benefit patients:

This preliminary work suggests that self-monitoring of BP during pregnancy is feasible and acceptable to women and that this intervention could improve the detection of raised BP during pregnancy. 

Assessment of blood pressure outside of a medical environment provides a more realistic estimation of blood pressure and is less intrusive than ambulatory BP monitoring. Self-monitoring could improve the detection of raised blood pressure in pregnancy and may represent a good way of differentiating white coat hypertension with true hypertension and thus avoid unnecessary medication during pregnancy.

BuMP Pilot paper 

BuMP Qualitative paper

Next steps:

This work has led to funding for the BUMP trials, which are now underway 


Full project title:

Self-monitoring of blood pressure in pregnancy: developing the evidence base in primary care.

Length of project:

18 months.

Funded by:


External collaborators:

  • Prof Sheila Greenfield - University of Birmingham, Qualitative research.
  • Dr James Hodgkinson - University of Birmingham, Qualitative research.
  • Prof Christine McCourt – City University London, Qualitative research.
  • Dr Lucy Mackillop - Oxford John Radcliffe Hospital, site P.I.
  • Dr Alex Pirie - Birmingham Women’s Hospital, site P.I.
  • Dr Margaret Glogowska, Mrs Tricia Carver and Dr Paula Cole - patient and public involvement representatives.
  • Liz Ewers and Lucy Ingram (Research midwives).
  • Midwives, GP’s and health professionals across Oxfordshire and Birmingham were involved in this research.

Research publications: